Ozgur, K. Et Al. 2022. Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.2 , 268-275.

Ozgur, K., Berkkanoglu, M., Bulut, H., Tore, H., DÖNMEZ, L., & Coetzee, K., (2022). Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.2, 268-275.

Ozgur, Kemal Et Al. "Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles," JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.2, 268-275, 2022

Ozgur, Kemal Et Al. "Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.2, pp.268-275, 2022

Ozgur, K. Et Al. (2022) . "Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles." JOURNAL OF OBSTETRICS AND GYNAECOLOGY , vol.42, no.2, pp.268-275.

@article{article, author={Kemal Ozgur Et Al. }, title={Dydrogesterone versus medroxyprogesterone acetate co-treatment ovarian stimulation for IVF: a matched cohort study of 236 freeze-all-IVF cycles}, journal={JOURNAL OF OBSTETRICS AND GYNAECOLOGY}, year=2022, pages={268-275} }